These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16457902)

  • 1. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy.
    Saido TC; Iwata N
    Neurosci Res; 2006 Apr; 54(4):235-53. PubMed ID: 16457902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.
    Saido TC
    Proc Jpn Acad Ser B Phys Biol Sci; 2013; 89(7):321-39. PubMed ID: 23883611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Towards presymptomatic diagnosis, prevention and treatment of Alzheimer's disease].
    Saido TC
    Rinsho Shinkeigaku; 2004 Nov; 44(11):775-7. PubMed ID: 15651288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
    Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
    Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
    Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention.
    Eckman EA; Eckman CB
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1101-5. PubMed ID: 16246055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E; Saido TC
    Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.
    Russo R; Borghi R; Markesbery W; Tabaton M; Piccini A
    FEBS Lett; 2005 Nov; 579(27):6027-30. PubMed ID: 16226260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
    J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Hellström-Lindahl E; Ravid R; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid.
    Yanagisawa K
    Neuroscientist; 2005 Jun; 11(3):250-60. PubMed ID: 15911874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'?
    Moro ML; Collins MJ; Cappellini E
    Biochem Soc Trans; 2010 Apr; 38(2):539-44. PubMed ID: 20298218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.